Clin Lab. 2024 Nov 1;70(11). doi: 10.7754/Clin.Lab.2024.240424.
Recombinase polymerase amplification (RPA) is a novel nucleic acid isothermal amplification technique that can achieve rapid detection of the target, under 37 to 42°C conditions, within 30 minutes. It has the advantage of extreme sensitivity, strong specificity, and low instrument dependency and is particularly suitable for real-time detection in the field. It can be widely used in fields such as in vitro diagnostics, biosafety, and agriculture. This study was based on RPA technology, targeting the gyrA gene of Neisseria gonorrhoeae (N. gonorrhoeae), to establish a quick, accurate, and easy to operate method for detecting N. gonorrhoeae and to evaluate its specificity, sensitivity, and clinical, practical value.
Specific primers and probes suitable for RPA and qPCR methods based on the specific conserved region of the gyrA gene of N. gonorrhoeae on GenBank (no. U08817.1) were designed An RPA method was developed and N. gonorrhoeae ATCC49226 and a number of clinical isolates were used as study subjects to validate the specificity and sensitivity of the RPA method for the detection of N. gonorrhoeae. A real-time fluorescence quantitative polymerase chain reaction (qPCR) method, with N. gonorrhoeae ATCC49226 as the research object, was established to verify the sensitivity of qPCR method for detecting N. gonorrhoeae. Finally, clinical samples were tested by using RPA and qPCR methods as performance validation experiments to determine the clinical utility of the RPA technique in detecting N. gonorrhoeae.
The established RPA detection method showed excellent specificity, with a specific amplification curve for N. gonorrhoeae alone, no cross-reactivity with other bacteria, and excellent reproducibility. The detection results could be obtained within 30 minutes, under the condition of 39°C, which was significantly lower than the detection time of traditional methods. The sensitivity of the RPA method for detecting pathogenic bacteria samples was 4 × 102 CFU/mL, which is consistent with the detection limit of qPCR methods. RPA and qPCR methods were used to detect 121 clinical isolates, out of which 30 strains of N. gonorrhoeae showed a specific amplification curve, while the remaining 91 strains of non-N. gonorrhoeae did not. Both methods had 100% accuracy and specificity in detecting N. gonorrhoeae.
The RPA method developed in this study has the characteristics of being quick, accurate, and easy to operate, which was of great value for the rapid detection of N. gonorrhoeae in clinical samples.
重组酶聚合酶扩增(RPA)是一种新型的核酸等温扩增技术,可在 37 至 42°C 的条件下,于 30 分钟内实现目标的快速检测。它具有极高的灵敏度、强特异性和低仪器依赖性的优点,特别适用于现场实时检测。它可以广泛应用于体外诊断、生物安全和农业等领域。本研究基于 RPA 技术,针对淋病奈瑟菌(N. gonorrhoeae)的 gyrA 基因,建立了一种快速、准确、易于操作的检测淋病奈瑟菌的方法,并评价其特异性、灵敏度和临床实用性。
根据淋病奈瑟菌 gyrA 基因在 GenBank 上的特定保守区域(编号 U08817.1),设计了适合 RPA 和 qPCR 方法的特异性引物和探针。建立了 RPA 方法,并以淋病奈瑟菌 ATCC49226 和一些临床分离株为研究对象,验证了 RPA 方法检测淋病奈瑟菌的特异性和灵敏度。以淋病奈瑟菌 ATCC49226 为研究对象,建立了实时荧光定量聚合酶链反应(qPCR)方法,验证了 qPCR 方法检测淋病奈瑟菌的灵敏度。最后,通过使用 RPA 和 qPCR 方法进行性能验证实验,检测临床样本,确定 RPA 技术在检测淋病奈瑟菌中的临床应用价值。
建立的 RPA 检测方法具有优异的特异性,仅对淋病奈瑟菌产生特异性扩增曲线,与其他细菌无交叉反应,具有良好的重现性。在 39°C 条件下,30 分钟内即可获得检测结果,明显低于传统方法的检测时间。RPA 方法检测病原菌样本的灵敏度为 4×102CFU/mL,与 qPCR 方法的检测限一致。使用 RPA 和 qPCR 方法检测 121 例临床分离株,其中 30 株淋病奈瑟菌显示出特异性扩增曲线,而其余 91 株非淋病奈瑟菌则没有。两种方法在检测淋病奈瑟菌时均具有 100%的准确性和特异性。
本研究建立的 RPA 方法具有快速、准确、易于操作的特点,对临床样本中淋病奈瑟菌的快速检测具有重要价值。